ULTI.OL - Ultimovacs ASA

Ultimovacs ASA

ULTI.OL

OSL

Inactive Equity

Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

2.05 NOK

0 (0%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Mar 4, 2025 10:25 AM

Share Price on Valuation Date

$2.05

Stock Beta

0.785

Shares Outstanding

34406100

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.